Location History:
- Vanløse, DK (2011)
- Vanlose, DK (2011)
Company Filing History:
Years Active: 2011
Title: The Innovative Contributions of Corinne Eenschooten
Introduction
Corinne Eenschooten is a notable inventor based in Vanløse, Denmark, recognized for her contributions to the field of biopolymers. With a focus on improving the properties of hyaluronic acid derivatives, her work has significant implications for both the cosmetic and biomedical industries.
Latest Patents
Corinne holds a patent related to the modification of hyaluronic acid (HA) using aryl/alkyl succinic anhydrides (ASA). This innovative approach results in the creation of ASA-HA derivatives that exhibit superior formulation capabilities, particularly in binding stronger to the skin compared to non-modified HA. Furthermore, these derivatives may enhance the delivery systems for active ingredients or drugs by utilizing methods such as encapsulation in nanoparticles or the formation of microspheres. The lower molecular weight ASA-HA derivatives are anticipated to penetrate the skin more effectively than their non-modified counterparts of equivalent molecular weight.
Career Highlights
Corinne is currently affiliated with Novozymes Biopolymer A/S, a company renowned for its focus on sustainable biopolymers and innovative solutions. Her work there is characterized by a strong commitment to developing advanced materials that have the potential to transform industries and improve product efficacy.
Collaborations
In her professional endeavors, Corinne collaborates closely with Kristoffer Tømmeraas, sharing insights and expertise that drive innovation forward. Their partnership exemplifies the power of teamwork in the realm of research and development, enabling them to tackle complex challenges and enhance the impact of their work.
Conclusion
Corinne Eenschooten is a trailblazer in the field of biopolymer research, with her innovative approach to hyaluronic acid derivatives setting new standards in the cosmetics and biomedical sectors. Her patent not only represents an important advance in the scientific community but also highlights the potential for further advancements in skin care and medicinal applications. As she continues her work with Novozymes Biopolymer A/S, the impact of her contributions is bound to grow, paving the way for future innovations.